Linde PLC (LIN)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 453.00 |
|---|---|
| 52-week range | 332.40 – 479.40 |
| Return, 1 month / 3 months | +12.1% / +2.3% |
| Return, 1 year / 3 years | +17.7% / +35.7% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 20.3% |
| Worst drawdown (1 year) | -16.4% |
| Average daily value traded | 4.42M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Linde is an industrial gases and engineering company that supplies atmospheric and process gases, including oxygen, nitrogen, argon, hydrogen and carbon dioxide, along with the equipment and services needed to produce and handle them. Its customers come from healthcare, manufacturing, chemicals, electronics, food and beverage, and other industries that rely on gases for their operations. The company also designs and builds plants for gas production and processing, and it is based in the United Kingdom.
On this site Linde PLC appears as a stock on the XETRA Stock Exchange (Germany), code LIN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Linde PLC (LIN) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 453.00 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 63 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.7% and over the last three months it rose 2.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.1% | ||
| From 52-week high | -4.9% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.3% | ||
| 6-month return | 7.0% | ||
| 12-month return, skipping the last month | 5.0% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.4% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 4.42M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +12.1% |
| 3 months | +2.3% |
| 6 months | +7.0% |
| 1 year | +17.7% |
| 3 years | +35.7% |
| 5 years | +79.1% |
Signals
| 50-day / 200-day average | 419.07 / 422.91 |
|---|---|
| Golden / death cross (60 days) | Death, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | GBP 1.4232 |
| 4 Jun 2026 | GBP 1.4232 |
| 11 Mar 2026 | GBP 1.4232 |
| 3 Dec 2025 | GBP 1.3343 |
| 4 Sep 2025 | GBP 1.3343 |
| 4 Jun 2025 | GBP 1.3343 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.